Cargando…
A tRNA-derived fragment of ginseng protects heart against ischemia/reperfusion injury via targeting the lncRNA MIAT/VEGFA pathway
Traditional Chinese medicines (TCMs) have been widely used for treating ischemic heart disease (IHD), and secondary metabolites are generally regarded as their pharmacologically active components. However, the effects of nucleic acids in TCMs remain unclear. We reported for the first time that a 22-...
Autores principales: | Hu, Kua, Yan, Tong-Meng, Cao, Kai-Yue, Li, Fang, Ma, Xiao-Rong, Lai, Qiong, Liu, Jin-Cheng, Pan, Yu, Kou, Jun-Ping, Jiang, Zhi-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440274/ https://www.ncbi.nlm.nih.gov/pubmed/36090756 http://dx.doi.org/10.1016/j.omtn.2022.08.014 |
Ejemplares similares
-
LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
por: Tan, Jin, et al.
Publicado: (2019) -
lncRNA MIAT promotes cell invasion and migration in esophageal cancer
por: Zhang, Weiguo, et al.
Publicado: (2020) -
Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure
por: Yang, Liu, et al.
Publicado: (2021) -
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
por: Todoerti, Katia, et al.
Publicado: (2021) -
Role of tRNA derived fragments in renal ischemia–reperfusion injury
por: Li, Dan, et al.
Publicado: (2022)